U.S. Researchers Identify Possible Ovarian Cancer Treatment Target

A multi-institutional study has identified a potential personalized treatment target for the most common form of ovarian cancer. In the Dec. 8 issue of Cancer Cell, the research team describes finding that a gene called MAGP2 -- not previously associated with any type of cancer -- was overexpressed in papillary serous ovarian tumors of patients who died more quickly. They also found evidence suggesting possible mechanisms by which MAGP2 may promote tumor growth.